Asthma
Conditions
Keywords
Asthma, Pharmaceutical intervention, Effect of a pharmaceutical intervention on the level of control of the asthmatic patient
Brief summary
Measurement of disease control, treatment adherence and patient knowledge of his/her medication in patients that are receiving a pharmaceutical intervention compared with those patients who receive regular pharmaceutical care.
Interventions
OTHER1
In the pilot study the objective is to compare 2 different pharmaceutical interventions (A and B) and to assess which one improves disease control, patient adherence and patient knowledge of the medication.
OTHER2
The best intervention used in the pilot study will be chosen and included in the main study.
Sponsors
AstraZeneca
Study design
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients who have given their informed consent and expressed interest in participating in the study * Asthmatic Patients
Exclusion criteria
* Patients with communication difficulties. * Persons who obtain symbicort but not for their own use. * Patients with other major diseases: Heart problems, COPD, EMPHYSEMA, lung cancer, AIDS. * Patients with a respiratory infection. * Patients with seasonal asthma. * Pregnant women * Patients who have previously participated in a health education study in asthma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the effect of the pharmaceutical intervention on the disease control, treatment adherence and patient knowledge of his/her medication using the MEF, treatment adherence and patient knowledge of the medication indicators. | First a Pilot in 3 months and then the final study in 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Compare disease control in patients who know their medication and those who doesn't. | First a Pilot in 3 months and then the final study in 6 months |
| Compare disease control in patients who comply with their medication with those who doesn't. | First a Pilot in 3 months and then the final study in 6 months |
Countries
Spain
Outcome results
None listed